More and more people in India are getting diabetes, which is changing the market direction in that area. A larger number of people don't exercise, eat poorly, and have diabetes-prone DNA. This explains the rise in diabetes cases. Now, there is a huge market for things and services related to diabetes because of this.
There is good news for the diabetes market in India: more people are learning about it and how important it is to found early. There has been a clear change toward stricter health management thanks to the work of drug companies, healthcare organizations, and government programs. And because of this, more people are being told they have diabetes earlier.
There are big changes happening in the market for devices that check glucose levels. These devices are becoming more high-tech. Continuous glucose monitoring (CGM) and smart insulin pens simplify diabetes treatment. This is because they give patients more accurate data that is updated in real time. A lot of people are using this way because it fits with the trend around the world toward personalized and digital health care.
New medicines are being made all the time to treat and prevent diabetes. This is a trend in the drug business. There are now more medicines on the market than ever before. These medicines work in more ways and are better at what they do. This new idea is a big step forward because it will make treatments work better and give patients and doctors more choices.
A big trend in the Indian market right now is diabetes drugs that don't cost a lot of money. People who are afraid about how much it will cost to treat diabetes can get help from the government and from drug makers and healthcare groups working together. Getting these important diabetes drugs cheaper so that more people can get them is the main goal.
The COVID-19 spread has made some people notice that telemedicine and online patient tracking are being used more often. With these tools, you can always keep an eye on your patients and check in on them often. This could make taking care of diabetes easy and better. This is very helpful for people who live in the country or a long way away.
More and more, tech companies, healthcare services, and drug companies are likely to connect with each other and work together. The goal of these deals is to make better diabetic care by combining medical knowledge, new technology, and market reach to give people all the help they need.
Indian government is trying hard to stop the spread of diabetes. This is clear from the many rules and programs it has set up. This includes efforts to teach people about diabetes, health care programs paid for by the government, and rules that make sure things and services connected to diabetes are of good quality and not too expensive. These things have a big impact on how market trends change over time.
AI is being employed in diabetes care, specifically predictive analytics to detect diabetes early and provide personalized treatment programs. AI is being applied in healthcare, revolutionizing diabetic treatment. AI makes healthcare more personalized and effective for everyone.
 
The India diabetes market size was valued at USD 6.75 Billion in 2023 and is projected to grow from USD 6.86 Billion in 2024 to USD 11.46 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.54% during the forecast period (2024 - 2032). Diabetes is a chronic metabolic condition that results in high blood glucose levels, which seriously harms the heart, blood vessels, eyes, kidneys, and nerves. Drugs used to treat diabetes are known as diabetic therapies, which consist of oral diabetes medications and human insulin mimics.
The leading causes of diabetes mellitus in Indians are obesity, particularly central obesity, increased visceral fat brought on by physical inactivity, and diets high in calories, fat, and sugar. The most prevalent work culture that is still practised in the nation, which involves consuming fast food while engaging in little to no physical exercise and spending hours in one position while seated, is a major factor in the rapid rise in diabetes incidence among India's working-age population. Additionally, the rising number of diabetic people and its growing prevalence and expanding use of insulin-delivery and continuous glucose monitoring devices are propelling market expansion. In India, 77 million people were estimated to have diabetes in 2019, and by 2045, that number is expected to reach over 134 million. About 57% of these people are still undiagnosed. However, problems faced by poor individuals across India in managing diabetes care are major restraining factors for the market.
The said market segment has been segmented based on type which comprises Type 1, Type 2, and Gestational diabetes.
Based on tests, the market is segmented into Random blood sugar tests, Fasting blood sugar tests, Oral glucose tolerance tests, Initial glucose challenge tests and others.
Based on devices, it is segmented into Blood glucose monitoring devices, Diabetes management devices, and others.
Based on treatment, the market is segmented into Medications, Insulin therapy, Transplantation, Bariatric surgery and Blood Sugar Treatment.
Considering the scenario of the Indian diabetes market, the western region is believed to be the largest market share holder for diabetes care. Moreover, the Eastern and Northern regions are also growing and the second-largest market for India's Diabetes treatment sector. On the other hand, the Southern Indian market is expected to grow at a significant rate in the Indian diabetes market during the forecasted period. The central region is likely to have limited but moderate growth in the said market segment.
India Diabetes Market Key Players Insights
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)